+Search query
-Structure paper
Title | Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva. |
---|---|
Journal, issue, pages | JCI Insight, Vol. 6, Year 2021 |
Publish date | Jun 18, 2020 (structure data deposition date) |
Authors | Williams, E. / Bagarova, J. / Kerr, G. / Xia, D.D. / Place, E.S. / Dey, D. / Shen, Y. / Bocobo, G.A. / Mohedas, A.H. / Huang, X. ...Williams, E. / Bagarova, J. / Kerr, G. / Xia, D.D. / Place, E.S. / Dey, D. / Shen, Y. / Bocobo, G.A. / Mohedas, A.H. / Huang, X. / Sanderson, P.E. / Lee, A. / Zheng, W. / Economides, A.N. / Smith, J.C. / Yu, P.B. / Bullock, A.N. |
External links | JCI Insight / PubMed:33705358 |
Methods | X-ray diffraction |
Resolution | 2.67 Å |
Structure data | PDB-6zgc: |
Chemicals | ChemComp-H8H: ChemComp-K: ChemComp-PO4: ChemComp-HOH: |
Source |
|
Keywords | SIGNALING PROTEIN / Inhibitor complex. Kinase. Type I receptor / BMP / Signalling. |